MENU
IVVD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Invivyd (IVVD) Ownership - Who owns Invivyd?
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential... Show more
Profile
Industry
N/A
Address
1601 Trapelo Road
Phone
+1 781 819-0080
Employees
95
Web
https://www.invivyd.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
95.72M
P/E Ratio
N/A
Total Cash
48.08M
Projected Growth
N/A
Total Debt
894K
Revenue
36.69M
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
N/A
Revenue/Share
0.31 USD as % of share price
Fundamentals
IVVD
Capitalization
95.7M
P/E Ratio
N/A
Risk (Beta)
1.38
Dividend Yield
N/A
Total Cash
48.1M
Total Cash/Share
0.40
Total Debt
894K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.31%
Revenue
36.7M
ROE
N/A
Book Value
54.1M
P/B Ratio
1.77
Cash Flow
N/A
Earnings
-1.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
1.53
Current Revenue Per Employee
113040.00
Dividends Per Share - Security
N/A
EBITDA
-144.38M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.62
Revenue To Assets
-89.42
Shares Held By Institutions
48M
Shares Outstanding - Current
120M
Total Liabilities
49.6M
Total Volume MTD
N/A
Value
1
Gain YTD
80.072
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IVVD showed earnings on May 15, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1601 Trapelo Road
Phone
+1 781 819-0080
Employees
95
Web
https://www.invivyd.com